J&J, Mazor Robotics, Stryker & more: 11 device company notes

Here are 11 key notes on orthopedic and spine device companies from the past week.

Advertisement

Johnson & Johnson acquired Orthotaxy, a privately-held developer of software-enabled surgery technologies, including a robotic-assisted surgery solution.

 

Medtronic reported $7.3 billion in third quarter 2018 revenue, a 1 percent increase over the same period last year.

 

Nexxt Spine reported the 250th implantation of its NEXXT MATRIXX System.

 

Orthopedic surgical navigation manufacturer OrthAlign passed a significant clinical milestone, with 75,000 navigation-assisted joint arthroplasty cases performed with OrthAlign technology.

 

Integra LifeSciences agreed to lease a 110,000-square-foot portion of an industrial building at Cabot Business Park in Mansfield, Mass.

 

Life Spine launched a new website to provide hospitals, health systems and surgeons more information on its Micro-Invasive Expandable products.

 

Stryker ranked No. 16 out of 100 on Fortune Magazine’s Best Companies to Work For list.

 

Mazor Robotics CEO Ori Hadomi spoke on several topics during the 2017 earnings call earlier this week, including the future for both the Renaissance and Mazor X systems.

 

Simplify Medical concluded enrollment for its U.S. investigational device exemption trial testing the Simplify cervical artificial disc.

 

Enrollment completed for Spineology’s SCOUT clinical trial.

 

After crossing the 95 percent threshold in Vexim, Stryker plans to file a public buy-out offer followed by a squeeze-out for outstanding Vexim shares.

 

More articles on devices and implants:
3 things to know about the 3M Attest Rapid Readout Biological Indicator System
The FDA requested $400M extra funding for these 8 initiatives
University of Indianapolis engineering students develop custom wrist orthosis

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • From new product launches and leadership appointments, here are seven key headlines from Stryker in the first quarter of 2026.…

  • Xtant Medical’s 2025 revenue reached $133.9 million, a 14% increase year over year, according to financial results posted March 31.…

Advertisement

Comments are closed.